Review



stearoyl coenzyme  (Proteintech)


Bioz Verified Symbol Proteintech is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    Proteintech stearoyl coenzyme
    Stearoyl Coenzyme, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 144 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/stearoyl coenzyme/product/Proteintech
    Average 96 stars, based on 144 article reviews
    stearoyl coenzyme - by Bioz Stars, 2026-03
    96/100 stars

    Images



    Similar Products

    96
    Proteintech stearoyl coenzyme
    Stearoyl Coenzyme, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/stearoyl coenzyme/product/Proteintech
    Average 96 stars, based on 1 article reviews
    stearoyl coenzyme - by Bioz Stars, 2026-03
    96/100 stars
      Buy from Supplier

    94
    Croda International Plc stearoyl coa
    Stearoyl Coa, supplied by Croda International Plc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/stearoyl coa/product/Croda International Plc
    Average 94 stars, based on 1 article reviews
    stearoyl coa - by Bioz Stars, 2026-03
    94/100 stars
      Buy from Supplier

    90
    Shanghai Yuanye Biotechnology stearoyl coenzyme
    Stearoyl Coenzyme, supplied by Shanghai Yuanye Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/stearoyl coenzyme/product/Shanghai Yuanye Biotechnology
    Average 90 stars, based on 1 article reviews
    stearoyl coenzyme - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    94
    Santa Cruz Biotechnology stearoyl coenzyme a desaturase
    Stearoyl Coenzyme A Desaturase, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/stearoyl coenzyme a desaturase/product/Santa Cruz Biotechnology
    Average 94 stars, based on 1 article reviews
    stearoyl coenzyme a desaturase - by Bioz Stars, 2026-03
    94/100 stars
      Buy from Supplier

    96
    Proteintech stearoyl coenzyme a desaturase 1
    Stearoyl Coenzyme A Desaturase 1, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/stearoyl coenzyme a desaturase 1/product/Proteintech
    Average 96 stars, based on 1 article reviews
    stearoyl coenzyme a desaturase 1 - by Bioz Stars, 2026-03
    96/100 stars
      Buy from Supplier

    90
    ABclonal Biotechnology stearoyl-coenzyme desaturase(scd
    Stearoyl Coenzyme Desaturase(Scd, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/stearoyl-coenzyme desaturase(scd/product/ABclonal Biotechnology
    Average 90 stars, based on 1 article reviews
    stearoyl-coenzyme desaturase(scd - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    Taiyo Nippon Sanso 13 c 18 stearoyl ( 13 c 18 18:0) coenzyme a
    sn -1 LPLAT activities are detected in a wide range of cells and tissues. A–C, sn -1 LPLAT activities in various mouse tissues and cells. A: LPLAT assays were performed using sn -2-rich LPC (oleoyl (C18:1) LPC ( <xref ref-type=Fig. 1 A)) as acyl acceptors, stearoyl-CoA (C18:0-CoA, upper), and palmitoyl-CoA (C16:0-CoA, lower) as acyl donors and membrane fractions of various mouse tissues as enzyme sources. B, C, LPLAT assays were performed using sn-2 -rich LPC (C18:1 LPC) and sn -1-rich LPC (stearoyl (C18:0) LPC) as acyl acceptors, C18:0-CoA, C16:0-CoA and arachidonoyl (C20:4)-CoA as acyl donors and membrane fractions of mouse tissues (liver and cerebrum, B) and culture cells (HeLa and HEK293A, C) as enzyme sources. Data are shown as the mean ± SD of three data points. The data are representative of two independent experiments with similar results. " width="250" height="auto" />
    13 C 18 Stearoyl ( 13 C 18 18:0) Coenzyme A, supplied by Taiyo Nippon Sanso, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/13 c 18 stearoyl ( 13 c 18 18:0) coenzyme a/product/Taiyo Nippon Sanso
    Average 90 stars, based on 1 article reviews
    13 c 18 stearoyl ( 13 c 18 18:0) coenzyme a - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    Image Search Results


    sn -1 LPLAT activities are detected in a wide range of cells and tissues. A–C, sn -1 LPLAT activities in various mouse tissues and cells. A: LPLAT assays were performed using sn -2-rich LPC (oleoyl (C18:1) LPC ( <xref ref-type=Fig. 1 A)) as acyl acceptors, stearoyl-CoA (C18:0-CoA, upper), and palmitoyl-CoA (C16:0-CoA, lower) as acyl donors and membrane fractions of various mouse tissues as enzyme sources. B, C, LPLAT assays were performed using sn-2 -rich LPC (C18:1 LPC) and sn -1-rich LPC (stearoyl (C18:0) LPC) as acyl acceptors, C18:0-CoA, C16:0-CoA and arachidonoyl (C20:4)-CoA as acyl donors and membrane fractions of mouse tissues (liver and cerebrum, B) and culture cells (HeLa and HEK293A, C) as enzyme sources. Data are shown as the mean ± SD of three data points. The data are representative of two independent experiments with similar results. " width="100%" height="100%">

    Journal: Journal of Lipid Research

    Article Title: Identification and characterization of LPLAT7 as an sn -1-specific lysophospholipid acyltransferase

    doi: 10.1016/j.jlr.2022.100271

    Figure Lengend Snippet: sn -1 LPLAT activities are detected in a wide range of cells and tissues. A–C, sn -1 LPLAT activities in various mouse tissues and cells. A: LPLAT assays were performed using sn -2-rich LPC (oleoyl (C18:1) LPC ( Fig. 1 A)) as acyl acceptors, stearoyl-CoA (C18:0-CoA, upper), and palmitoyl-CoA (C16:0-CoA, lower) as acyl donors and membrane fractions of various mouse tissues as enzyme sources. B, C, LPLAT assays were performed using sn-2 -rich LPC (C18:1 LPC) and sn -1-rich LPC (stearoyl (C18:0) LPC) as acyl acceptors, C18:0-CoA, C16:0-CoA and arachidonoyl (C20:4)-CoA as acyl donors and membrane fractions of mouse tissues (liver and cerebrum, B) and culture cells (HeLa and HEK293A, C) as enzyme sources. Data are shown as the mean ± SD of three data points. The data are representative of two independent experiments with similar results.

    Article Snippet: 13 C 16 Palmitoyl ( 13 C 16 16:0) coenzyme A and 13 C 18 stearoyl ( 13 C 18 18:0) coenzyme A were purchased from Taiyo Nippon Sanso (Tokyo, Japan).

    Techniques: Membrane

    siRNA screening for sn -1 LPLATs. HeLa and HEK293A cells were treated with either siRNA for each LPLAT (LPLAT1 (AGPAT1), LPLAT2 (AGPAT2), LPLAT3 (AGPAT3), LPLAT4 (AGPAT4), LPLAT5 (AGPAT5), LPLAT6 (LCLAT1), LPLAT7 (LPGAT1), LPLAT8 (LPCAT1), LPLAT9 (LPCAT2), LPLAT10 (LPCAT4), LPLAT11 (MBOAT7), LPLAT13 (MBOAT2), and LPLAT14 (MBOAT1) or negative control siRNA. The resulting membrane fractions were used for sn -1 LPLAT assays using sn -2-rich LPC (oleoyl (C18:1) LPC, <xref ref-type=Fig. 1 A) as an acyl acceptor and stearoyl-CoA (C18:0-CoA, A: HeLa, B: HEK293A) and palmitoyl-CoA (C16:0-CoA, C: HeLa, D: HEK293A) as acyl donors. Data are shown as the mean ± SD of three data points. The data are representative of two independent experiments with similar results. " width="100%" height="100%">

    Journal: Journal of Lipid Research

    Article Title: Identification and characterization of LPLAT7 as an sn -1-specific lysophospholipid acyltransferase

    doi: 10.1016/j.jlr.2022.100271

    Figure Lengend Snippet: siRNA screening for sn -1 LPLATs. HeLa and HEK293A cells were treated with either siRNA for each LPLAT (LPLAT1 (AGPAT1), LPLAT2 (AGPAT2), LPLAT3 (AGPAT3), LPLAT4 (AGPAT4), LPLAT5 (AGPAT5), LPLAT6 (LCLAT1), LPLAT7 (LPGAT1), LPLAT8 (LPCAT1), LPLAT9 (LPCAT2), LPLAT10 (LPCAT4), LPLAT11 (MBOAT7), LPLAT13 (MBOAT2), and LPLAT14 (MBOAT1) or negative control siRNA. The resulting membrane fractions were used for sn -1 LPLAT assays using sn -2-rich LPC (oleoyl (C18:1) LPC, Fig. 1 A) as an acyl acceptor and stearoyl-CoA (C18:0-CoA, A: HeLa, B: HEK293A) and palmitoyl-CoA (C16:0-CoA, C: HeLa, D: HEK293A) as acyl donors. Data are shown as the mean ± SD of three data points. The data are representative of two independent experiments with similar results.

    Article Snippet: 13 C 16 Palmitoyl ( 13 C 16 16:0) coenzyme A and 13 C 18 stearoyl ( 13 C 18 18:0) coenzyme A were purchased from Taiyo Nippon Sanso (Tokyo, Japan).

    Techniques: Negative Control, Membrane

    Biochemical characterization of LPLAT7. A, B, Preference of LPLAT7 for sn -2 lysophospholipids. A: LPLAT activities of LPLAT7 against LPC. Oleoyl (C18:1) LPCs (both sn -2-rich and sn -1-rich, 20 μM) and stearoyl (C18:0)-CoA (4 μM) were used as acyl acceptors and an acyl donor, respectively. Membrane fractions from HEK293A cells transfected with a human LPLAT7 expression vector or an empty vector (Mock) were used as enzyme sources. B: Kinetic analyses of LPTAT7 activities. Substrate concentration dependence of LPLAT7 was determined with the indicated concentrations of LPCs (both sn -2-rich and sn -1-rich) in the presence of C18:0-CoA (4 μM). C, D, Determination of the glycerol sn positions into which LPLAT7 introduces a fatty acid. C: LPLAT activities of LPLAT7 against LPC using a set of labeled LPCs and a labeled-acyl-CoA. Palmitoyl (C16:0)- d 31 LPCs (both sn -2-rich and sn -1-rich, 10 μM) and 13 C 18 18:0-CoA (2 μM) were used as acyl acceptors and an acyl donor, respectively. D: The ratio of two labeled fatty acids at the sn -1 position of the LPLAT7 reaction products. The reaction products of LPLAT7 in (C) were subjected to a PLA 2 reaction. The amount of the resulting two sn -1-acyl LPCs (1– 13 C 18 18:0-2-hydroxy-GPC and 1-16:0- d 31 -2-hydroxy-GPC) was determined by LC-MS/MS. E: LPLAT activities of LPLAT7 toward acyl acceptors with different head groups. Various sn -2-rich C18:1 lyso-PLs (LPC, LPE, LPS, LPG and LPA) and soy LPI, each 20 μM and C18:0-CoA (4 μM) were used. F: Kinetic analyses of LPTAT7 activities. Substrate concentration dependence of LPLAT7 was determined with the indicated concentrations of LPCs or LPEs in the presence of C18:0-CoA (4 μM). G: LPLAT activities of LPLAT7 toward the three acyl donors, determined using C16:0-CoA, C18:1-CoA, or C18:0-CoA (4 μM) with sn -2-rich C18:1 LPC (20 μM). H: Kinetic analyses of LPTAT7 activities. Substrate concentration dependence of LPLAT7 was determined with the indicated concentrations of acyl-CoAs (C18:0-, C18:1- and C16:0-CoAs) in the presence of sn -2-rich C18:1 LPC (20 μM). I: LPLAT activities of LPLAT7 toward various acyl acceptors with different fatty acids. Several LPCs (C16:0, C18:1, linoleoyl (C18:2), arachidonoyl (C20:4), and docosahexaenoyl (C22:6), each 20 μM) and C18:0-CoA (4 μM) were used.

    Journal: Journal of Lipid Research

    Article Title: Identification and characterization of LPLAT7 as an sn -1-specific lysophospholipid acyltransferase

    doi: 10.1016/j.jlr.2022.100271

    Figure Lengend Snippet: Biochemical characterization of LPLAT7. A, B, Preference of LPLAT7 for sn -2 lysophospholipids. A: LPLAT activities of LPLAT7 against LPC. Oleoyl (C18:1) LPCs (both sn -2-rich and sn -1-rich, 20 μM) and stearoyl (C18:0)-CoA (4 μM) were used as acyl acceptors and an acyl donor, respectively. Membrane fractions from HEK293A cells transfected with a human LPLAT7 expression vector or an empty vector (Mock) were used as enzyme sources. B: Kinetic analyses of LPTAT7 activities. Substrate concentration dependence of LPLAT7 was determined with the indicated concentrations of LPCs (both sn -2-rich and sn -1-rich) in the presence of C18:0-CoA (4 μM). C, D, Determination of the glycerol sn positions into which LPLAT7 introduces a fatty acid. C: LPLAT activities of LPLAT7 against LPC using a set of labeled LPCs and a labeled-acyl-CoA. Palmitoyl (C16:0)- d 31 LPCs (both sn -2-rich and sn -1-rich, 10 μM) and 13 C 18 18:0-CoA (2 μM) were used as acyl acceptors and an acyl donor, respectively. D: The ratio of two labeled fatty acids at the sn -1 position of the LPLAT7 reaction products. The reaction products of LPLAT7 in (C) were subjected to a PLA 2 reaction. The amount of the resulting two sn -1-acyl LPCs (1– 13 C 18 18:0-2-hydroxy-GPC and 1-16:0- d 31 -2-hydroxy-GPC) was determined by LC-MS/MS. E: LPLAT activities of LPLAT7 toward acyl acceptors with different head groups. Various sn -2-rich C18:1 lyso-PLs (LPC, LPE, LPS, LPG and LPA) and soy LPI, each 20 μM and C18:0-CoA (4 μM) were used. F: Kinetic analyses of LPTAT7 activities. Substrate concentration dependence of LPLAT7 was determined with the indicated concentrations of LPCs or LPEs in the presence of C18:0-CoA (4 μM). G: LPLAT activities of LPLAT7 toward the three acyl donors, determined using C16:0-CoA, C18:1-CoA, or C18:0-CoA (4 μM) with sn -2-rich C18:1 LPC (20 μM). H: Kinetic analyses of LPTAT7 activities. Substrate concentration dependence of LPLAT7 was determined with the indicated concentrations of acyl-CoAs (C18:0-, C18:1- and C16:0-CoAs) in the presence of sn -2-rich C18:1 LPC (20 μM). I: LPLAT activities of LPLAT7 toward various acyl acceptors with different fatty acids. Several LPCs (C16:0, C18:1, linoleoyl (C18:2), arachidonoyl (C20:4), and docosahexaenoyl (C22:6), each 20 μM) and C18:0-CoA (4 μM) were used.

    Article Snippet: 13 C 16 Palmitoyl ( 13 C 16 16:0) coenzyme A and 13 C 18 stearoyl ( 13 C 18 18:0) coenzyme A were purchased from Taiyo Nippon Sanso (Tokyo, Japan).

    Techniques: Membrane, Transfection, Expressing, Plasmid Preparation, Concentration Assay, Labeling, Liquid Chromatography with Mass Spectroscopy

    LPLAT7 is the major sn -1 LPLAT in the mouse liver and human culture cells. (A, B and C) Membrane fractions of the liver from wild-type (green bars), Lplat7 heterozygous (blue bars) and Lplat7 homozygous (red bars) mice were tested for sn -1 LPLAT assays using various sn -2-rich oleoyl (C18:1) lysophospholipids (except for soy LPI) as acyl acceptors and stearoyl (C18:0)-CoA (A), palmitoyl (C16:0)-CoA (B) or oleoyl (C18:1)-CoA (C) as acyl donors. The relative LPLAT activities of wild-type mice being 100% are shown. Data are shown as the mean ± SD of 4–5 mice sample for each group. The data are representative of two independent experiments with similar results. (D, E and F) Membrane fractions of the HEK293 A parent cells (wild-type, black bars), LPLAT7 KO clone#20 (light blue bars), LPLAT7 KO clone#58 (orange bars) and LPLAT7 KO clone#116 (purple bars) were measured for sn -1 LPLAT assays using various sn -2-rich C18:1 lysophospholipids (except for soy LPI) as acyl acceptors and C18:0-CoA (D) or C16:0-CoA (E) or 18:1-CoA (F) as acyl donors. The relative LPLAT activities of parent cells (wild-type) being 100% are shown. Data are shown as the mean ± SD of three data points. The data are representative of two independent experiments with similar results. Statistically significant differences (WT vs. HT and WT vs. KO or Parent vs. KO #20, KO #58 and KO #116) are marked with asterisks indicating P -values. ∗ P <0.05; ∗∗ P <0.01; ∗∗∗ P <0.001; ∗∗∗∗ P <0.0001; ns indicates not significant; two-way ANOVA, Bonferroni’s multiple comparison test.

    Journal: Journal of Lipid Research

    Article Title: Identification and characterization of LPLAT7 as an sn -1-specific lysophospholipid acyltransferase

    doi: 10.1016/j.jlr.2022.100271

    Figure Lengend Snippet: LPLAT7 is the major sn -1 LPLAT in the mouse liver and human culture cells. (A, B and C) Membrane fractions of the liver from wild-type (green bars), Lplat7 heterozygous (blue bars) and Lplat7 homozygous (red bars) mice were tested for sn -1 LPLAT assays using various sn -2-rich oleoyl (C18:1) lysophospholipids (except for soy LPI) as acyl acceptors and stearoyl (C18:0)-CoA (A), palmitoyl (C16:0)-CoA (B) or oleoyl (C18:1)-CoA (C) as acyl donors. The relative LPLAT activities of wild-type mice being 100% are shown. Data are shown as the mean ± SD of 4–5 mice sample for each group. The data are representative of two independent experiments with similar results. (D, E and F) Membrane fractions of the HEK293 A parent cells (wild-type, black bars), LPLAT7 KO clone#20 (light blue bars), LPLAT7 KO clone#58 (orange bars) and LPLAT7 KO clone#116 (purple bars) were measured for sn -1 LPLAT assays using various sn -2-rich C18:1 lysophospholipids (except for soy LPI) as acyl acceptors and C18:0-CoA (D) or C16:0-CoA (E) or 18:1-CoA (F) as acyl donors. The relative LPLAT activities of parent cells (wild-type) being 100% are shown. Data are shown as the mean ± SD of three data points. The data are representative of two independent experiments with similar results. Statistically significant differences (WT vs. HT and WT vs. KO or Parent vs. KO #20, KO #58 and KO #116) are marked with asterisks indicating P -values. ∗ P <0.05; ∗∗ P <0.01; ∗∗∗ P <0.001; ∗∗∗∗ P <0.0001; ns indicates not significant; two-way ANOVA, Bonferroni’s multiple comparison test.

    Article Snippet: 13 C 16 Palmitoyl ( 13 C 16 16:0) coenzyme A and 13 C 18 stearoyl ( 13 C 18 18:0) coenzyme A were purchased from Taiyo Nippon Sanso (Tokyo, Japan).

    Techniques: Membrane, Comparison